Predictive Factors for Medullary Thyroid Cancer Aggressiveness
MYELO
Predective Factors for Tumor Aggressiveness in Medullary Thyroid Cancer
1 other identifier
observational
500
24 countries
46
Brief Summary
This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Shorter than P25 for all trials
46 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
March 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2024
CompletedJanuary 3, 2025
March 1, 2024
2 months
February 19, 2024
January 2, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Central lymph node metastasis
Central neck compartment lymph node metastasis
Number of lymph node Metastasis found in preoperative imaging studies or up to 1 year postoperatively
Lateral lymph node metastasis
Lateral neck compartment lymph node metastasis
Number of lymph node Metastasis found in preoperative imaging studies or up to 1 year postoperatively
Distant metastasis
Liver and lung metastasis
Number of distant Metastasis found in preoperative imaging studies or up to 1 year postoperatively
Secondary Outcomes (10)
Nuclear atypia as histological predictor of aggressiveness
The pathology report is held immediately after surgery
Amyloid as histological predictor of aggressiveness
The pathology report is held immediately after surgery
Immunohistochemistry as histological predictor of aggressiveness
The pathology report is held immediately after surgery
Desmoplasia as histological predictor of aggressiveness
The pathology report is held immediately after surgery
CEA as Biochemical predictor of aggressiveness
pre and postoperative laboratory exams up to 1 year postoperatively
- +5 more secondary outcomes
Interventions
Total thyroidectomy
Eligibility Criteria
All patients \>18 years old who underwent surgery for medullary thyroid cancer are enrolled in this study
You may qualify if:
- Patients who underwent thyroidectomy for medullary thyroid cancer (total thyroidectomy, completion thyroidectomy) +/- central/lateral neck dissection
You may not qualify if:
- Age \< 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (46)
Oregon Health & Science University, Oregon
Oregon City, Oregon, 97239, United States
Department of Surgery, Saint John of God Hospital, Salzburg, Austria
Salzburg, Austria
Saint Luc, University Clouvain, Belgium
Brussels, Belgium
Head and Neck Surgery Department, Hospital Ana Nery, Santa Cruz do Sul, Brazil
Santa Cruz do Sul, Brazil
University Clinic of Surgery, University Hospital "Lozenec"
Sofia, Bulgaria
Chinese University of Hong Kong
Hong Kong, China
Head and Neck Department Oncologos del Occidente, Universidad de Caldas, Manizales, Colombia
Manizales, Colombia
the University Hospital Center Sestre milosrdnice, Zagreb, Croatia, Department of Otorhinolaryngology and Head and Neck Surgery
Zagreb, Croatia
Head and Neck Surgery, Brest University Hospital, Brest, France
Brest, France
The University Hospital of Poitiers, France
Poitiers, France
Thyroid Surgery Clinic IKE, Athens, Greece
Athens, Greece
ENT Department University Hospital of Larissa
Larissa, Greece
Department of Surgery, General University Hospital of Patras
Pátrai, Greece
Aristotle University of Thessaloniki
Thessaloniki, Greece
Gennimatas General Hospital
Thessaloniki, Greece
Department of ENT-Head and Neck Surgery, All India Institute of Medical Sciences, Bhubaneswar
Bhubaneswar, India
KMCH and KMCH Comprehensive Cancer Center
Coimbatore, India
Department of Endocrine and Breast Surgery at Sanjay Gandhi Post Graduate Institute of Medical Sciences
Madurai, India
Department of Surgery, Maulana Azad Medical College & Lok Nayak Hospital
New Delhi, India
Endocrine and Metabolic Surgery, Bhargav Endocrine Hospital, Vijayawada, India
Vijayawada, India
University of Sulaimani | UNIVSUL ,Department of Surgery, Kurdistan
Erbil, Iraq
ASL VCO - San Biagio Hospital - Domodossola (VB) - Italy
Domodossola, Italy
Dipartimento di Scienze Chirurgiche (DISC), University of Genoa, Italy
Genoa, Italy
Asst Santi Paolo e Carlo - Ospedale Polo Universitario San Paolo, Milan, Italy
Milan, Italy
UOC Chirurgia Endocrina e Metabolica, Fondazione Policlinico Universitario A Gemelli IRCCS
Roma, Italy
Department of Medical and Surgical Sciences, University of Trieste, Cattinara Teaching Hospital, Trieste, Italy
Trieste, Italy
Department of Surgery and Oncology, Endocrine Surgery Unit, Verona University Hospital
Verona, Italy
Hashemite University of Zarqa
Zarqa, Jordan
Hepatobiliairy and endocrine surgery, Ibn Sina Hospital, Medical School of Medecine Rabat, Mohamed Vth University of Rabat Morocco
Marrakesh, Morocco
Division of General, Endocrine and Transplant Surgery, Medical University of Gdańsk
Gdansk, Poland
Surgical Oncology Clinic, Institute for Oncology and Radiology of Serbia, Medical School, University of Belgrade
Belgrade, Serbia
Comenius University in Bratislava, Department of Paediatric Surgery, National Institute of Children's Diseases
Bratislava, Slovakia
Department of oncological surgery, St. Elisabeth cancer Institute
Bratislava, Slovakia
Hospital Clinic (Barcelona, Spain)
Barcelona, Spain
Universitaria de Cordoba
Córdoba, Spain
Hospital Regional de Málaga
Málaga, Spain
Department of General and Digestive Surgery, Division of Endocrine Surgery, Complexo Hospitalario Universitario de Vigo, Vigo, Spain
Vigo, Spain
Bern University Hospital
Bern, Switzerland
Geneva University Hospital
Geneva, Switzerland
Division of Endocrinology and Metabolism Department of Medicine Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok, Thailand
Bangkok, Thailand
Ankara University Faculty of Medicine, Department of Endocrine Surgery
Ankara, Turkey (Türkiye)
Acibadem MAA University
Istanbul, Turkey (Türkiye)
Cerrahpasa medical faculty endocrine surgery department
Istanbul, Turkey (Türkiye)
Department of Endocrin Pathology Unit, University of Health Sciences, Faculty of Medicine, Bakırköy Dr Sadi Konuk Training and Research Hospital, Istanbul, Turkey
Istanbul, Turkey (Türkiye)
Endocrine surgeon-consultant, International medical center "CITIDOCTOR"
Kyiv, Ukraine
Department of Radiology, Thien Hanh Hospital, Buon Ma Thuot, Vietnam
Việt Trì, Vietnam
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Theodossis Papavramidis, Prof
1st Propedeutic Department of Surgery, AHEPA University Hospital of Thessaloniki, Greece
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 19, 2024
First Posted
March 5, 2024
Study Start
March 1, 2024
Primary Completion
April 15, 2024
Study Completion
April 15, 2024
Last Updated
January 3, 2025
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share